Expired Tender USA ICB TOT Ref. 6879637

Expand The Bone Marrow Screening Program Tender in USA - 6879637

Tender notice from USA, published on 10 Jun 2016.

Executive Summary

The DEPARTMENT OF THE NAVY has issued a Tender notice for the procurement of a Expand The Bone Marrow Screening Program And Continue To Improve The Typing Resolution And Accuracy By Continuing Improvements In The Solid Phase Based System Paired With Dna Sequencing For Hla In Sup... in the USA. This Tender notice was published on 10 Jun 2016 and is scheduled to close on 14 Jun 2016, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 6879637, while the tender notice number is N32398BONEMARROW2 and Register on the platform.

Key facts

Summary
Expand The Bone Marrow Screening Program And Continue To Improve The Typing Resolution And Accuracy By Continuing Improvements In The Solid Phase Based System Paired With Dna Sequencing For Hla In Sup...
TOT Ref. No.
6879637
Document Ref. No.
N32398BONEMARROW2
Country
USA
Notice type
Tender
Competition
ICB
Publication date
10 Jun 2016
Bid deadline
14 Jun 2016
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
-
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

The naval medical logistics command (nmlc) is seeking sources to support the department of defense (dod) in expanding the bone marrow screening program by improving the typing resolution and accuracy through continuous improvements in the solid phase (bead) based system paired with deoxyribonucleic acid (dna) sequencing for human leukocyte antigen (hla) in support of naval medical research center (nmrc), silver spring md. The objective is to develop an hla typing system for donors that allow transplant centers searching for matched donors to identify these individuals positively through complete allele level data on the search files used by the nmrc program to support potential patients and causalities of marrow toxic exposure. The estimated period of performance of the project is 12 months.
If capable sources are not identified through this notice, then nmlc intends to award a sole source contract under the authority of far 6.302-1 to one lambda, incorporation (inc.), 21001 kittridge street, canoga park, ca 91303-2801 for the performance of the described requirement.
One lambda, inc. Is the only source that has developed a high resolution (hd) rsso (reverse sequence-specific oligonucleotide) dna typing reagents in the labtype product family and accompanying in vitro diagnostic medical devices (ivd) analysis software (hla fusion). The collaboration of one lambda, inc. With nmrc since 2007 has been successful in continuing to develop specific probes to improve assay resolution and to meet the typing requirements of the dod hla typing program and bone marrow registry under the c.w. Bill young marrow donor program.
One lambda inc. Is the only source that will continue to develop and manufacture new sso typing kits to support nmrc donor recruitment hla-a, hla-b, hla-c, hla-drb, hla-dqb and hla-dpab alleles to detect and discriminate between alleles found in the dod bone marrow donor pool, even if they are rare in the general population. One lambda will use 2 patents assigned by the u.s. Patent office to continue this research. Further, one lambda, inc. Is the only source who will continue to use the solid phase bead system and be paired with dna sequencing capable of simultaneously analyzing multiple hla loci as referenced above. This requires extensive use of both of one lambda s patents, exclusive license, and proprietary technology providing testing of tens of thousands of unique samples at research level genetic testing (allele level) with federal laboratory certification. One lambda inc. Will continue to develop and hla test library preparation protocols and integration of existing nmrc automation equipment so that the software will be consistent with products being delivered. Further, given its patents, one lambda, inc. Is the only company who can continue to develop dna primer pairs and sequence the 3.6 mb region of major histocompatibility complex genes and incorporate technology from this study into the existing proprietary bead/sequencing system used by nmrc to improve genetic matching for marrow transplantation.
This sources sought notice is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Capability statements shall not exceed 1 (8.5 x 11 inch) page using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the government. A request for documentation or additional information will not be considered as an affirmative response. A determination by the government not to compete based on responses to this notice is solely within the discretion of the government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source contract.
Capability statements are due by 5:00 pm eastern time, 14 june 2016. Capability statements shall be submitted by e-mail only as a microsoft word or adobe pdf attachment to the following address: [email protected].
503 robert grant avenue

silver spring, maryland 20910

united states
primary point of contact.:

ronald stephen sanford

[email protected] general information
a -- research & development

naics code:

541 -- professional, scientific, and technical services/541711 -- research and development in biotechnology
541 -- professional, scientific, and technical services/541711 -- research and development in biotechnology

for help: federal service deskaccessibility

added: jun 09, 2016 4:08 pm

Documents

Tender Notice
Login to view

Similar tenders

USA Public Procurement Intelligence

Frequently asked questions

The bid deadline for Expand The Bone Marrow Screening Program And Continue To Improve The Typing Resolution And Accuracy By Continuing Improvements In The Solid Phase Based System Paired With Dna Sequencing For Hla In Sup... was 14 Jun 2016. Bidding is closed.

This tender has been issued by DEPARTMENT OF THE NAVY in USA.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 71900000 - Laboratory services.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 6879637. The purchaser document reference is N32398BONEMARROW2.

See the Similar Tenders section on this page or browse other tenders from USA.

This tender falls under Construction and Real Estate in USA. Suppliers in these sectors can track similar USA tenders using CPV-based alerts.